Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy

Departament of Hematology and Cell Therapy, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), D’Or Institute for Research and Education (IDOR), Hospital Das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, Hospital Sirio Libanes, São Paulo, Brazil, Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy andMaterials (CNPEM), Campinas, Brazil, Department of Microbiology, Immunology and Cancer Biology, Office of Research Core Administration (ORCA), University of Virginia School of Medicine, Charlottesville, VA, United States, Department of Pathology, University of Virginia School of Medicine, Spatial Biology Core (SBC) Facility, Charlottesville, VA, United States

• Publication year

  2022

• Venue

  Frontiers in Cell and Developmental Biology

• Publication date

  2022-08-22

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3389/fcell.2022.971275PMID 36072339PMCID 9442672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome

  2025cites this paper
• FCGR2A contributes to M2 macrophages polarization in HCC through IL-4/JAK/STAT6 axis

  2025cites this paper
• Immunologische Grundlagen der Immunonkologie

  2025cites this paper
• Effects of serum HIF-1α, VEGF, and uPA levels on clinicopathologic findings and prognosis in oral squamous cell carcinoma.

  2025cites this paper
• Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives

  2024cites this paper
• Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications

  2024cites this paper
• Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives

  2024cites this paper
• Hallmarks of cancer resistance

  2024cites this paper
• The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers

  2024cites this paper
• MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer

  2023cites this paper
• Prognostic role of long non-coding RNA USP30-AS1 in ovarian cancer: insights into immune cell infiltration in the tumor microenvironment

  2023cites this paper
• Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment

  2023influential citation